-
3 Branded Formulation, Biologics and Pharma Service Stocks With a Strong Future Roadmap: Mankind Pharma, Shilpa Medicare and Indegene
- October 14, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
No Comments
Mankind Pharma, Shilpa Medicare and Indegene compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
3 Pharma Brand, Medical Device and Diagnostic Chain Stocks With a Strong Future Roadmap: Mankind Pharma, Poly Medicure and Suraksha Diagnostic
- October 13, 2026
- Posted by: Kunal Singla
- Category: Best Stocks
Mankind Pharma, Poly Medicure and Suraksha Diagnostic compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
3 Chronic Therapy, Enzyme and Pharmacy Retail Stocks With a Strong Future Roadmap: Mankind Pharma, Advanced Enzyme Technologies and Medplus Health Services
- October 13, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Mankind Pharma, Advanced Enzyme Technologies and Medplus Health Services compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
3 Trusted Medicine Brand Stocks With a Strong Future Roadmap: GlaxoSmithKline Pharmaceuticals, Mankind Pharma and FDC
- October 12, 2026
- Posted by: Ankit Jaiswal
- Category: Best Stocks
GlaxoSmithKline Pharmaceuticals, Mankind Pharma and FDC compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
3 Branded and Generic Pharma Stocks With a Strong Future Roadmap: Mankind Pharma, Alkem Laboratories and Aurobindo Pharma
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Best Stocks
Mankind Pharma, Alkem Laboratories and Aurobindo Pharma compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
Stock bought by Mutual Funds in May 2023
- June 16, 2023
- Posted by: Kashish Aggarwal
- Category: Market
